longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Dianthus Therapeutics

DNTH

105.2801.64% ( -1.760 )
Trading: Sep 10, 14:25:46 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -31.14, below the reasonable range, cheaper than 84.29% of the time in the past 1 years, and the industry ranks 517/600, the industry Median -2.59.

-31.14xP/E
$107.04Stock price
$-3.44Earnings per share
-31.14xP/E
Stock price$107.04Earnings per share$-3.44

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-23.52x
Typical range
-30.27x–-13.33x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
018365472

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-55.74x148.77%$180.60B
CSLLYUSCSL Limited
-23.03x--$59.39B
MRNAUSModerna
-17.18x15.79%$54.14B
NTRAUSNatera
-247.53x10.38%$47.61B
RVMDUSRevolution Medicines
-25.17x64.29%$44.51B
ROIVUSRoivant Sciences
-113.43x148.13%$30.20B
INSMUSInsmed
-32.13x74.55%$28.13B
BNTXUSBioNTech SE
-12.59x19.96%$24.65B
BBIOUSBridgebio Pharma
-21.50x28.75%$14.87B
SMMTUSSummit Therapeutics
-16.34x18.42%$13.99B
MDGLUSMadrigal Pharma
-38.85x50.86%$12.63B
ARWRUSArrowHead Pharma
-36.48x36,308.30%$11.67B
ABVXUSAbivax SA
-26.83x32.59%$10.41B
CYTKUSCytokinetics
-11.52x6.37%$10.30B
PRAXUSPraxis Precision Medicines
-28.43x3.05%$9.64B
KYMRUSKymera Therapeutics
-32.04x4.94%$9.60B
IONSUSIonis Pharma
-16.47x52.66%$9.31B
PCVXUSVaxcyte
-8.32x48.80%$8.86B
IBRXUSImmunityBio
-8.61x152.63%$8.54B
TWSTUSTwist Bioscience
-60.44x24.70%$8.26B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.